A detailed history of Gunderson Capital Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Gunderson Capital Management Inc. holds 85,553 shares of NVO stock, worth $12.2 Million. This represents 5.11% of its overall portfolio holdings.

Number of Shares
85,553
Previous 79,048 8.23%
Holding current value
$12.2 Million
Previous $8.18 Million 34.34%
% of portfolio
5.11%
Previous 4.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$102.11 - $135.92 $664,225 - $884,159
6,505 Added 8.23%
85,553 $11 Million
Q4 2023

Jan 05, 2024

BUY
$87.78 - $105.45 $1.02 Million - $1.22 Million
11,590 Added 17.18%
79,048 $8.18 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $3 Million - $6.59 Million
33,028 Added 95.93%
67,458 $6.13 Million
Q2 2023

Jul 10, 2023

SELL
$155.98 - $172.65 $347,679 - $384,836
-2,229 Reduced 6.08%
34,430 $5.57 Million
Q1 2023

Apr 11, 2023

BUY
$132.34 - $159.14 $4.85 Million - $5.83 Million
36,659 New
36,659 $5.83 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gunderson Capital Management Inc. Portfolio

Follow Gunderson Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunderson Capital Management Inc. with notifications on news.